Our study, for the first time, demonstrated with in vivo evidence that astrocyte-specific overexpression of hepcidin altered brain iron metabolism, and protected against Aβ-induced oxidative damage in mice, which provides more insights into the therapy of iron overloaded-related brain disorders. This evidence concerns the gene HAMP and brain disorder.